0
0
0
Ensuring Sufficient Supply of Testing Act
2/5/2024, 2:30 PM
Summary of Bill HR 3840
Bill 118 hr 3840, also known as the Ensuring Sufficient Supply of Testing Act, is a piece of legislation introduced in the US Congress with the goal of ensuring that there is an adequate supply of testing materials and resources available for COVID-19 testing.
The bill aims to address the ongoing challenges faced by healthcare providers and public health agencies in obtaining the necessary testing supplies to effectively test for the coronavirus. It seeks to increase the production and distribution of testing materials, such as swabs, reagents, and personal protective equipment, to meet the growing demand for testing across the country.
Additionally, the Ensuring Sufficient Supply of Testing Act includes provisions to improve coordination between federal, state, and local agencies in the procurement and distribution of testing supplies. It also calls for increased transparency in reporting on testing supply levels and distribution to ensure that resources are allocated efficiently and effectively. Overall, the bill is designed to enhance the nation's ability to conduct widespread testing for COVID-19, which is crucial for controlling the spread of the virus and protecting public health. It is currently being reviewed by Congress and has garnered bipartisan support for its efforts to address the testing supply shortages that have been a major obstacle in the fight against the pandemic.
The bill aims to address the ongoing challenges faced by healthcare providers and public health agencies in obtaining the necessary testing supplies to effectively test for the coronavirus. It seeks to increase the production and distribution of testing materials, such as swabs, reagents, and personal protective equipment, to meet the growing demand for testing across the country.
Additionally, the Ensuring Sufficient Supply of Testing Act includes provisions to improve coordination between federal, state, and local agencies in the procurement and distribution of testing supplies. It also calls for increased transparency in reporting on testing supply levels and distribution to ensure that resources are allocated efficiently and effectively. Overall, the bill is designed to enhance the nation's ability to conduct widespread testing for COVID-19, which is crucial for controlling the spread of the virus and protecting public health. It is currently being reviewed by Congress and has garnered bipartisan support for its efforts to address the testing supply shortages that have been a major obstacle in the fight against the pandemic.
Current Status of Bill HR 3840
Bill HR 3840 is currently in the status of Bill Introduced since June 6, 2023. Bill HR 3840 was introduced during Congress 118 and was introduced to the House on June 6, 2023. Bill HR 3840's most recent activity was Referred to the Subcommittee on Health. as of June 9, 2023
Bipartisan Support of Bill HR 3840
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 3840
Primary Policy Focus
HealthComments
Sponsors and Cosponsors of HR 3840
Latest Bills
NIH IMPROVE Act
Bill HR 6238August 19, 2026
Continuing Appropriations and Extensions Act, 2027
Bill HR 6500August 18, 2026
Permitting Transparency and Accountability Act
Bill S 1735August 18, 2026
Chiricahua National Park Act
Bill S 3715August 18, 2026
To designate the Christiansted Bandstand at the Christiansted National Historic Site, St. Croix, Virgin Islands, as the "Peter G. Thurland, Sr., Bandstand".
Bill HR 8121August 18, 2026
Parents Opt-in Protection Act
Bill HR 4986August 18, 2026
College Transparency Act
Bill S 2511August 18, 2026
Ratepayer Protection Act
Bill HR 9340August 18, 2026
RISE Act
Bill S 3589August 14, 2026
Federal Building Threat Notification Act
Bill S 2542August 14, 2026
